DOSSIER · UPDATED 18 NOV 2025
Amygdala Neurosciences
Amygdala Neurosciences is developing ANS-6637 a new chemical entity with a novel MOA for treating substance use disorder. Based on a mechanism of action in the brain (published in Nature Medicine) that prevents pathophysiologic dopamine…
This profile is unclaimed — do you work here? Claim it
Claim it →- Founded
- 2015
- Headcount
- 9
- Open roles
- 0
- Last raised
- Grant · $2M
LEADERSHIP
Founders & key people
OPEN ROLES
Hiring at Amygdala Neurosciences
No open roles listed right now. Check back soon or search all jobs →
FUNDING
Capital raised
TAGS
Categorized in
Company Collections
These are collections Amygdala Neurosciences is a part of. Click on the collection name to view similar companies.
Amygdala Neurosciences' Industries
LOCATIONS
Where they work
Amygdala Neurosciences Headquarters Location
509 Hale St, Palo Alto, CA, 94301
Loading map…